Video: Food and Drinks at Star Wars: Galaxy’s Edge Inside Disneyland Park

Watch video at You Tube (5:42 minutes) . . . . .

Advertisements

Nigella’s Tomato-y Eggs on Toast

Ingredients

3 tablespoons extra-virgin olive oil
8 small ripe tomatoes, about 12 oz total, Campari size, or at least bigger than cherry or grape tomatoes
1 tablespoon tomato paste
pinch of salt
pinch of sugar
2 large eggs
1 oz chunk pecorino Romano cheese
2 slices sourdough bread or whole-grain bread
small handful of basil leaves (may substitute leaves stripped from a few stems of thyme)

Method

  1. Heat the oil in a large, heavy skillet over medium heat.
  2. Cut the tomatoes in half, then into bite-size chunks, then add them to the pan. Cook for five minutes, stirring occasionally; the tomatoes should start to break down, oozing their juices.
  3. Stir in the tomato paste, salt and sugar. Cook for five minutes, by which time the tomato skins should be loosening and their juices mingling with the oil.
  4. For a creamier final consistency, pick the skins out and discard them.
  5. Crack in the eggs and stir as though you were scrambling them, until they form a creamy, tomato-y mass. This should take about three minutes.
  6. Remove from the heat, or cook them for a bit longer if you like your scrambled eggs firm.
  7. Grate or crumble half the cheese over the mixture in the pan. Let this sit while you toast the bread.
  8. Place a slice of toast on each plate. Spoon half the eggs onto each one, then grate or crumble the remaining cheese over, and tear and scatter the fresh herbs on top.
  9. Serve right away.

Makes 2 servings.

Source: Simply Nigella

In Pictures: Brunch Toast

Apple, Marshmallow and Nut Toast

Banana, Peanut Butter and Granola Toast

Orange Toast

Honey Toast

French Pancakes

Strawberry and Daifuku Toast

Taco Bell Is Planning a New Vegetarian Menu Free of Fake Meat

Jenny G. Zhang wrote . . . . . . . . .

It appears Taco Bell will not be joining so many of its fast-food brethren in the land of fake meat. After announcing in January that it would be testing its first dedicated vegetarian menu this year, Taco Bell revealed on Wednesday that the chain is not planning on working with Beyond Meat or Impossible Foods to add plant-based meat to its menu.

“We’ve met with Beyond, we’ve met with Impossible,” Julie Felss Masino, Taco Bell’s president of North American operations, told CNBC. “But I think what we’re proud of is that we’ve been doing vegetarian for 57 years.”

While other chains like Burger King, White Castle, and even taco competitor Del Taco have focused on meatless beef alternatives, Masino told Insider that Taco Bell is doubling down on its existing vegetarian protein options: the refried beans, black beans, and potatoes that already make Taco Bell an attractive option for non-meat eaters.

Taco Bell, which is the only American Vegetarian Association-certified fast-food chain in the country, boasts a relatively vegetarian-friendly menu, thanks in part to flexible personalization options. According to a company blog post, approximately nine percent of all items ordered at Taco Bell are either vegetarian or made vegetarian by customization, accounting for the sale of 350 million vegetarian items a year. The bean burrito — consisting of refried beans, cheese, onions, and red sauce in a tortilla — is Taco Bell’s no. 2 best-selling item, CNBC reports.

Source: Eater

New Blood Test for Detecting Alzheimer’s Disease

Researchers from Lund University, together with the Roche pharmaceutical company, have used a method to develop a new blood marker capable of detecting whether or not a person has Alzheimer’s disease. If the method is approved for clinical use, the researchers hope eventually to see it used as a diagnostic tool in primary healthcare. This autumn, they will start a trial in primary healthcare to test the technique.

Currently, a major support in the diagnostics of Alzheimer’s disease is the identification of abnormal accumulation of the substance beta-amyloid, which can be detected either in a spinal fluid sample or through brain imaging using a PET scanner.

“These are expensive methods that are only available in specialist healthcare. In research, we have therefore long been searching for simpler diagnostic tools”, says Sebastian Palmqvist, associate professor at the unit for clinical memory research at Lund University, physician at Skåne University Hospital and lead author of the study.

In this study, which is a collaboration between several medical centres, the researchers investigated whether a simple blood test could identify people in whom beta-amyloid has started to accumulate in the brain, i.e. people with underlying Alzheimer’s disease. Using a simple and precise method that the researchers think is suitable for clinical diagnostics and screening in primary healthcare, the researchers were able to identify beta-amyloid in the blood with a high degree of accuracy.

“Previous studies on methods using blood tests did not show particularly good results; it was only possible to see small differences between Alzheimer’s patients and healthy elderly people. Only a year or so ago, researchers found methods using blood sample analysis that showed greater accuracy in detecting the presence of Alzheimer’s disease. The difficulty so far is that they currently require advanced technology and are not available for use in today’s clinical procedures”, says Sebastian Palmqvist.

The results are published in JAMA Neurology and based on studies of blood analyses collected from 842 people in Sweden (The Swedish BioFINDER study) and 237 people in Germany. The participants in the study are Alzheimer’s patients with dementia, healthy elderly people and people with mild cognitive impairment.

The method studied by the researchers was developed by Roche and is a fully automated technique which measures beta-amyloid in the blood, with high accuracy in identifying the protein accumulation.

“We have collaborated with Roche for a long time and it is only now that we are starting to approach a level of accuracy that is usable in routine clinical care around the world”, says Oskar Hansson, professor of neurology and head of the unit for clinical memory research at Lund University.

The researchers believe that this new blood sample analysis could be an important complement for screening individuals for inclusion in clinical drug trials against Alzheimer’s disease or to improve the diagnostics in primary care which will allow more people to get the currently available symptomatic treatment against Alzheimer’s disease.

“The next step to confirm this simple method to reveal beta-amyloid through blood sample analysis is to test it in a larger population where the presence of underlying Alzheimer’s is lower. We also need to test the technique in clinical settings, which we will do fairly soon in a major primary care study in Sweden. We hope that this will validate our results”, concludes Sebastian Palmqvist.

Source : Lund University


Today’s Comic